-
1
المؤلفون: Charlotte L M Krieckaert, Lea C. Berkhout, Michael T. Nurmohamed, Gerrit Jan Wolbink, Theo Rispens, Dorien Kos, Erik H Vogelzang, Merel J l'Ami
المساهمون: AII - Inflammatory diseases, Graduate School, Landsteiner Laboratory, ACS - Atherosclerosis & ischemic syndromes, Rheumatology
المصدر: Rheumatology (Oxford, England), 59(7), 1703-1708. Oxford University Press
Rheumatology (United Kingdom), 59(7), 1703-1708. Oxford University Press
Berkhout, L C, L'Ami, M J, Krieckaert, C L M, Vogelzang, E H, Kos, D, Nurmohamed, M T, Wolbink, G J & Rispens, T 2020, ' The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients ', Rheumatology (United Kingdom), vol. 59, no. 7, pp. 1703-1708 . https://doi.org/10.1093/rheumatology/kez513مصطلحات موضوعية: 0301 basic medicine, musculoskeletal diseases, Adult, medicine.medical_specialty, Necrosis, medicine.medical_treatment, TNF, immunogenicity, MTX, Gastroenterology, Etanercept, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Interquartile range, Internal medicine, medicine, Adalimumab, Humans, Pharmacology (medical), skin and connective tissue diseases, 030203 arthritis & rheumatology, business.industry, Tumor Necrosis Factor-alpha, medicine.disease, 030104 developmental biology, Cytokine, Methotrexate, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Tumor necrosis factor alpha, Drug Therapy, Combination, medicine.symptom, business, RA, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043af7d6f3a7e658f88e864aa6c630e2
https://pubmed.ncbi.nlm.nih.gov/31691828 -
2
المؤلفون: Lea C, Berkhout, Erik H, Vogelzang, Margreet M, Hart, Floris C, Loeff, Lisanne, Dijk, Ninotska I L, Derksen, Roeland, Wieringa, W Astrid, van Leeuwen, Charlotte L M, Krieckaert, Annick, de Vries, Michael T, Nurmohamed, Gerrit J, Wolbink, Theo, Rispens
المصدر: Clinical and experimental rheumatology. 38(2)
مصطلحات موضوعية: Arthritis, Rheumatoid, Immunoglobulin Fab Fragments, Tumor Necrosis Factor-alpha, Antirheumatic Agents, Adalimumab, Certolizumab Pegol, Humans, Antibodies, Monoclonal, Humanized, Antibodies, Neutralizing, Antibodies, Infliximab
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::266561cf597d9f5586a130c9fe2f9f1d
https://pubmed.ncbi.nlm.nih.gov/31498069 -
3
المؤلفون: T. Rispens, Maarten Boers, Ronald F van Vollenhoven, Merel J l'Ami, Gerrit Jan Wolbink, Charlotte L M Krieckaert, Michael T. Nurmohamed
المساهمون: Rheumatology, ACS - Atherosclerosis & ischemic syndromes, AII - Inflammatory diseases, Epidemiology and Data Science, APH - Methodology, Landsteiner Laboratory, Clinical Immunology and Rheumatology, Amsterdam Movement Sciences, Amsterdam institute for Infection and Immunity
المصدر: Annals of the Rheumatic Diseases, 77(10). BMJ Publishing Group
Annals of the rheumatic diseases, 77(10):e68. BMJ Publishing Group
l'Ami, M J, Krieckaert, C L M, Nurmohamed, M T, van Vollenhoven, R F, Rispens, T, Boers, M & Wolbink, G J 2018, ' Response to : Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al ', Annals of the Rheumatic Diseases, vol. 77, no. 10, pp. e68 . https://doi.org/10.1136/annrheumdis-2017-212602مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Immunology, Population, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Non inferiority, Rheumatology, Internal medicine, medicine, Adalimumab, Immunology and Allergy, In patient, 030212 general & internal medicine, Dosing, education, 030203 arthritis & rheumatology, education.field_of_study, business.industry, medicine.disease, Clinical trial, Rheumatoid arthritis, Physical therapy, Open label, business, medicine.drug
-
4
المؤلفون: Gertjan Wolbink, Merel J. l’ Ami, J. Ruwaard, Wilfred van der Weele, Renske C. F. Hebing, Zohra Layegh, Charlotte L M Krieckaert, Michael T. Nurmohamed
المساهمون: ACS - Atherosclerosis & ischemic syndromes
المصدر: International Journal of Rheumatic Diseases, 22(5), 869-873. Wiley-Blackwell Publishing Ltd
مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, Time Factors, Population, Arthritis, Rheumatoid, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, Humans, 030212 general & internal medicine, skin and connective tissue diseases, education, Biosimilar Pharmaceuticals, Aged, Retrospective Studies, 030203 arthritis & rheumatology, Aged, 80 and over, education.field_of_study, medicine.diagnostic_test, business.industry, Drug Substitution, Arthritis, Psoriatic, Antibodies, Monoclonal, Biosimilar, Middle Aged, medicine.disease, Infliximab, Discontinuation, Clinical Practice, Treatment Outcome, Erythrocyte sedimentation rate, Rheumatoid arthritis, Antirheumatic Agents, Female, business, medicine.drug
-
5
المؤلفون: Maarten Boers, Ronald F van Vollenhoven, Charlotte L M Krieckaert, Theo Rispens, Merel J l'Ami, Michael T. Nurmohamed, Gerrit Jan Wolbink
المساهمون: Rheumatology, ACS - Atherosclerosis & ischemic syndromes, AII - Inflammatory diseases, Epidemiology and Data Science, APH - Methodology, Landsteiner Laboratory, Clinical Immunology and Rheumatology, AMS - Amsterdam Movement Sciences, AII - Amsterdam institute for Infection and Immunity
المصدر: Annals of the Rheumatic Diseases, 77(4), 484-487. BMJ Publishing Group
Annals of the rheumatic diseases, 77(4), 484-487. BMJ Publishing Group
l'Ami, M J, Krieckaert, C L, Nurmohamed, M T, van Vollenhoven, R F, Rispens, T, Boers, M & Wolbink, G J 2018, ' Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations : an open-label, non-inferiority, randomised clinical trial ', Annals of the Rheumatic Diseases, vol. 77, no. 4, pp. 484-487 . https://doi.org/10.1136/annrheumdis-2017-211781مصطلحات موضوعية: medicine.medical_specialty, Immunology, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Non inferiority, Rheumatology, Internal medicine, medicine, Adalimumab, Immunology and Allergy, In patient, 030212 general & internal medicine, skin and connective tissue diseases, 030203 arthritis & rheumatology, medicine.diagnostic_test, business.industry, High serum, medicine.disease, Surgery, Clinical trial, Therapeutic drug monitoring, Rheumatoid arthritis, Open label, business, medicine.drug
-
6
المؤلفون: Maarten Boers, Merel J l'Ami, Charlotte L M Krieckaert, Michael T. Nurmohamed, Theo Rispens, Gerrit Jan Wolbink, Ronald F van Vollenhoven
المساهمون: Clinical Immunology and Rheumatology, AII - Inflammatory diseases, AMS - Ageing & Morbidty, Landsteiner Laboratory, AMS - Musculoskeletal Health, Rheumatology, Epidemiology and Data Science, APH - Methodology, ACS - Atherosclerosis & ischemic syndromes
المصدر: Annals of the rheumatic diseases, 79(7):e82. BMJ Publishing Group
Annals of the Rheumatic Diseases, 79(7):e82. BMJ Publishing Group
l'Ami, M J, Krieckaert, C L, Nurmohamed, M T, van Vollenhoven, R F, Rispens, T, Boers, M & Wolbink, G J 2020, ' Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: Data from the STRASS study' by Marotte et al ', Annals of the Rheumatic Diseases, vol. 79, no. 7, e82 . https://doi.org/10.1136/annrheumdis-2019-215609مصطلحات موضوعية: rheumatoid arthritis, 0301 basic medicine, Drug, medicine.medical_specialty, TNF Blocker, media_common.quotation_subject, Immunology, DMARDs (biologic), Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Pharmacokinetics, Recurrence, Internal medicine, Adalimumab, medicine, Humans, Immunology and Allergy, media_common, 030203 arthritis & rheumatology, business.industry, anti-TNF, medicine.disease, 030104 developmental biology, Antirheumatic Agents, Rheumatoid arthritis, Tumor Necrosis Factor Inhibitors, Antirheumatic drugs, business, pharmacokinetics, medicine.drug
-
7
المؤلفون: Diana Wouters, Pauline A. van Schouwenburg, Charlotte L M Krieckaert, Gerrit Jan Wolbink, Lucien A. Aarden, Theo Rispens
المساهمون: Landsteiner Laboratory
المصدر: Annals of the rheumatic diseases, 72(10), 1680-1686. BMJ Publishing Group
مصطلحات موضوعية: Drug, Adult, Male, medicine.drug_class, media_common.quotation_subject, Immunology, Monoclonal antibody, Antibodies, Monoclonal, Humanized, Severity of Illness Index, General Biochemistry, Genetics and Molecular Biology, Arthritis, Rheumatoid, Rheumatology, Predictive Value of Tests, Adalimumab, Immunology and Allergy, Medicine, Humans, Prospective Studies, Treatment Failure, media_common, Aged, biology, business.industry, Immunogenicity, Remission Induction, Hydrogen-Ion Concentration, Middle Aged, medicine.disease, Antigen binding, Prognosis, Connective tissue disease, Antibodies, Anti-Idiotypic, Rheumatoid arthritis, Antirheumatic Agents, Antibody Formation, biology.protein, Female, Antibody, business, medicine.drug, Follow-Up Studies
-
8
المساهمون: Rheumatology, ICaR - Circulation and metabolism, MOVE Research Institute, CCA - Innovative therapy
المصدر: Rheumatology, 52(3), 547-553. Oxford University Press
Krieckaert, C L M, Nurmohamed, M T, Wolbink, G & Lems, W F 2013, ' Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study ', Rheumatology, vol. 52, no. 3, pp. 547-553 . https://doi.org/10.1093/rheumatology/kes320مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Time Factors, Arthritis, Lumbar vertebrae, Antibodies, Monoclonal, Humanized, Peptides, Cyclic, Arthritis, Rheumatoid, Cohort Studies, Absorptiometry, Photon, Rheumatology, Bone Density, Internal medicine, Adalimumab, medicine, Humans, Pharmacology (medical), Aged, Bone mineral, Hip, Lumbar Vertebrae, business.industry, Middle Aged, Hand, musculoskeletal system, medicine.disease, Surgery, medicine.anatomical_structure, Antirheumatic Agents, Rheumatoid arthritis, Osteoporosis, Female, business, Rheumatism, Cohort study, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92af1f8bd9167802828240c8844ca0ac
https://doi.org/10.1093/rheumatology/kes320 -
9
المؤلفون: Merel J, l'Ami, Eva L, Kneepkens, Michael T, Nurmohamed, Charlotte L M, Krieckaert, Ingrid M, Visman, Gert-Jan, Wolbink
المصدر: Clinical and experimental rheumatology. 35(3)
مصطلحات موضوعية: Adult, Male, Biological Products, Time Factors, Remission Induction, Adalimumab, Drug Synergism, Middle Aged, Severity of Illness Index, Etanercept, Arthritis, Rheumatoid, Methotrexate, Treatment Outcome, Antirheumatic Agents, Surveys and Questionnaires, Humans, Drug Therapy, Combination, Female, Prospective Studies, Aged
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::57c640920a6d88bc08e0b6dbe76d730e
https://pubmed.ncbi.nlm.nih.gov/28079512 -
10
المؤلفون: Charlotte L M Krieckaert, Theo Rispens, Gertjan Wolbink
المصدر: Current Opinion in Rheumatology. 24:306-311
مصطلحات موضوعية: Immunoassay, Biological Products, business.industry, Immunogenicity, Treatment outcome, MEDLINE, Immunoglobulins, Confounding Factors, Epidemiologic, chemical and pharmacologic phenomena, Bioinformatics, complex mixtures, Treatment Outcome, Immune system, Rheumatology, Humans, Medicine, Drug Monitoring, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a985e5b004b0889e47db6f2c029390
https://doi.org/10.1097/bor.0b013e3283521c4e
